Impact of low-dose quetiapine-use on glycosylated hemoglobin, triglyceride and cholesterol levels.

Højlund, Mikkel; Støvring, Henrik; Andersen, Kjeld; Correll, Christoph U; Hallas, Jesper

Højlund, Mikkel; Støvring, Henrik; Andersen, Kjeld; Correll, Christoph U; Hallas, Jesper.

Afiliação

Højlund M; Department of Public Health, Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark.
Støvring H; Mental Health Services Region of Southern Denmark, Department of Psychiatry Aabenraa, Aabenraa, Denmark.
Andersen K; Department of Public Health, Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark.
Correll CU; Department of Public Health, Aarhus University, Aarhus, Denmark.
Hallas J; Department of Clinical Medicine, Psychiatry, University of Southern Denmark, Odense, Denmark.

Acta Psychiatr Scand ; 147(1): 105-116, 2023 01.

Article em En | MEDLINE | ID: mdl-36281759

Assuntos

Hemoglobinas Glicadas; Feminino; Humanos; Pessoa de Meia-Idade; HDL-Colesterol; LDL-Colesterol; Fumarato de Quetiapina/efeitos adversos; Triglicerídeos; Masculino

Palavras-chave

Antipsychotics; dyslipidemia; hyperglycemia; off-label; quetiapine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemoglobinas Glicadas Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google